Circulating interferon–α and soluble CD25 are associated with distinct pulmonary phenotypes in untreated early rheumatoid arthritis

Abstract Background Pulmonary abnormalities (PA) of airways and parenchyma are prevalent in rheumatoid arthritis (RA), and interstitial lung disease (ILD) is a severe extra-articular manifestation affecting up to 10% of patients. Yet, the immune mechanisms underlying the different forms of pulmonary involvement and the relationships between them remain incompletely understood. We investigated whether distinct pulmonary phenotypes in untreated patients with newly diagnosed RA are associated with specific systemic immune profiles. Methods This cross-sectional study included 55 consecutive treatment-naïve patients with newly diagnosed autoantibody-positive RA who underwent high-resolution computed tomography of the lungs. Presence of bronchiectasis, bronchial wall thickening, air trapping, reticulations, ground-glass opacities, traction bronchiectasis, honeycombing, pleural effusion and parenchymal nodules was evaluated by thoracic radiologists in consensus. Serum cytokines, chemokines and growth factors were quantified using a 48-plex immunoassay, neutrophil elastase by ELISA, and interferon α (IFN–α) by Single molecule array (Simoa) ultra-sensitive immunoassay. A type I interferon gene score was determined by RT-PCR based on the mean gene expression of IFI6 , IFI44L , ISG15 , MX1 and OAS1 . Multivariate data analyses were followed by predefined univariate validation of the five highest-ranked variables associated with 1) parenchymal nodules, 2) interstitial lung abnormalities (ILA) and 3) airway abnormalities. Sensitivity analyses and correlations with clinical parameters were performed. Results Pulmonary abnormalities were identified in 78% of the untreated early (ue) RA patients. Despite substantial overlap between the pulmonary phenotypes, both airway abnormalities and parenchymal nodules were present as isolated phenotypes. A presence of any PA was strongly associated with rheumatoid factor IgM and systemic inflammation. Higher levels of soluble CD25 were associated with parenchymal nodules, whereas ILA was associated with increased IFN–α levels and higher Disease Activity Score in 28 joints. The most significant markers of airway abnormalities were increased CRP and shorter symptom duration. Conclusions Pulmonary phenotypes in ueRA are associated with different inflammatory and immune activation profiles and suggest IFN–α as a candidate biomarker for ILD development. Whether the lungs represent a primary site of autoimmune events during the development of RA or an extra-articular site of RA-related inflammation remains to be determined.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11435024/v1
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Circulating interferon–α and soluble CD25 are associated with distinct pulmonary phenotypes in untreated early rheumatoid arthritis

Henrik Zetterberg, Monica Leu Agelii, Tilia Selldén, Åse Allansdotter Johnsson et al.
Research Square
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
preprint

Circulating interferon–α and soluble CD25 are associated with distinct pulmonary phenotypes in untreated early rheumatoid arthritis

Henrik Zetterberg, Monica Leu Agelii, Tilia Selldén, Åse Allansdotter Johnsson, Martina Sundqvist, Spela Kokelj, Anna‐Karin Hultgård Ekwall, Anna Rudin, Josefin Björklin, Anna‐Carin Lundell, Daniel Glinatsi, Beatrice Bergström, Inger Gjertsson, Fredrik Ahlfors
preprint en

Abstract

Abstract Background Pulmonary abnormalities (PA) of airways and parenchyma are prevalent in rheumatoid arthritis (RA), and interstitial lung disease (ILD) is a severe extra-articular manifestation affecting up to 10% of patients. Yet, the immune mechanisms underlying the different forms of pulmonary involvement and the relationships between them remain incompletely understood. We investigated whether distinct pulmonary phenotypes in untreated patients with newly diagnosed RA are associated with specific systemic immune profiles. Methods This cross-sectional study included 55 consecutive treatment-naïve patients with newly diagnosed autoantibody-positive RA who underwent high-resolution computed tomography of the lungs. Presence of bronchiectasis, bronchial wall thickening, air trapping, reticulations, ground-glass opacities, traction bronchiectasis, honeycombing, pleural effusion and parenchymal nodules was evaluated by thoracic radiologists in consensus. Serum cytokines, chemokines and growth factors were quantified using a 48-plex immunoassay, neutrophil elastase by ELISA, and interferon α (IFN–α) by Single molecule array (Simoa) ultra-sensitive immunoassay. A type I interferon gene score was determined by RT-PCR based on the mean gene expression of IFI6 , IFI44L , ISG15 , MX1 and OAS1 . Multivariate data analyses were followed by predefined univariate validation of the five highest-ranked variables associated with 1) parenchymal nodules, 2) interstitial lung abnormalities (ILA) and 3) airway abnormalities. Sensitivity analyses and correlations with clinical parameters were performed. Results Pulmonary abnormalities were identified in 78% of the untreated early (ue) RA patients. Despite substantial overlap between the pulmonary phenotypes, both airway abnormalities and parenchymal nodules were present as isolated phenotypes. A presence of any PA was strongly associated with rheumatoid factor IgM and systemic inflammation. Higher levels of soluble CD25 were associated with parenchymal nodules, whereas ILA was associated with increased IFN–α levels and higher Disease Activity Score in 28 joints. The most significant markers of airway abnormalities were increased CRP and shorter symptom duration. Conclusions Pulmonary phenotypes in ueRA are associated with different inflammatory and immune activation profiles and suggest IFN–α as a candidate biomarker for ILD development. Whether the lungs represent a primary site of autoimmune events during the development of RA or an extra-articular site of RA-related inflammation remains to be determined.

Research Square
Skaraborg Hospital (SE), University of Gothenburg (SE)
Västra Götalandsregionen, Rune och Ulla Amlövs Stiftelse för Neurologisk och Reumatologisk Forskning, European Commission, Vetenskapsrådet, Sahlgrenska Universitetssjukhuset, Göteborgs Universitet, Reumatikerförbundet, Stiftelsen Mary von Sydows, född Wijk, donationsfond, HORIZON EUROPE Framework Programme
Good health and well-being
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon